PCR.WA
PCC Rokita SA [PCR.WA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PCR.WA Stock Summary
Top 10 Correlated ETFs
PCR.WA
Top 10 Correlated Stocks
PCR.WA
In the News
PCR.WA Financial details
Company Rating
Strong Buy
Market Cap
2.02B
Income
267.84M
Revenue
2.39B
Book val./share
69.58
Cash/share
14.49
Dividend
21.57
Dividend %
22.06%
Employees
1.45K
Optionable
No
Shortable
Yes
Earnings
21 Mar 2024
P/E
4.11
Forward P/E
-
PEG
-0.68
P/S
0.7
P/B
1.49
P/C
6.94
P/FCF
3.8
Quick Ratio
0.9
Current Ratio
1.32
Debt / Equity
0.43
LT Debt / Equity
0.36
-
-
EPS (TTM)
13.49
EPS next Y
-
EPS next Q
-
EPS this Y
-60.32%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
23.48%
Revenue last 5Y
9.87%
Revenue Q/Q
4.49%
EPS Q/Q
176.67%
-
-
-
-
SMA20
-3.81%
SMA50
6.32%
SMA100
12.22%
Inst Own
-
Inst Trans
-
ROA
19%
ROE
33%
ROC
0.32%
Gross Margin
32%
Oper. Margin
22%
Profit Margin
17%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
81.1-152.2
52W High
-33.82%
52W Low
+24.2%
RSI
46
Rel Volume
0.23
Avg Volume
3.44K
Volume
793
Perf Week
-0.59%
Perf Month
2.65%
Perf Quarter
13.93%
Perf Half Y
4.79%
-
-
-
-
Beta
1.188
-
-
Volatility
0.64%, 2.27%
Prev Close
0.4%
Price
100.6
Change
0%
PCR.WA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 75.15 | 74.34 | 110.98 | 158.3 | 120.29 | |
| Net income per share | 4.7 | 5.91 | 21.02 | 34 | 13.49 | |
| Operating cash flow per share | 15.62 | 18.41 | 26.69 | 39.91 | 25.79 | |
| Free cash flow per share | 3.87 | 9.84 | 19.15 | 28.36 | 14.9 | |
| Cash per share | 3.29 | 8.76 | 16.15 | 26.57 | 14.49 | |
| Book value per share | 37.11 | 39.63 | 56.94 | 77.72 | 69.58 | |
| Tangible book value per share | 28.97 | 33.23 | 48.87 | 68.13 | 60.44 | |
| Share holders equity per share | 37.11 | 39.63 | 56.94 | 77.72 | 69.58 | |
| Interest debt per share | 42.38 | 42.19 | 35.12 | 33.5 | 31.74 | |
| Market cap | 970.81M | 1.03B | 1.82B | 1.9B | 1.93B | |
| Enterprise value | 1.72B | 1.67B | 2.17B | 2.01B | 2.24B | |
| P/E ratio | 10.41 | 8.76 | 4.36 | 2.81 | 7.22 | |
| Price to sales ratio | 0.65 | 0.7 | 0.83 | 0.6 | 0.81 | |
| POCF ratio | 3.13 | 2.81 | 3.43 | 2.4 | 3.78 | |
| PFCF ratio | 12.63 | 5.26 | 4.78 | 3.37 | 6.54 | |
| P/B Ratio | 1.32 | 1.31 | 1.61 | 1.23 | 1.4 | |
| PTB ratio | 1.32 | 1.31 | 1.61 | 1.23 | 1.4 | |
| EV to sales | 1.15 | 1.13 | 0.99 | 0.64 | 0.94 | |
| Enterprise value over EBITDA | 6.44 | 5.34 | 3.31 | 1.97 | 4.31 | |
| EV to operating cash flow | 5.55 | 4.56 | 4.1 | 2.54 | 4.38 | |
| EV to free cash flow | 22.37 | 8.53 | 5.72 | 3.58 | 7.59 | |
| Earnings yield | 0.1 | 0.11 | 0.23 | 0.36 | 0.14 | |
| Free cash flow yield | 0.08 | 0.19 | 0.21 | 0.3 | 0.15 | |
| Debt to equity | 1.11 | 1.03 | 0.6 | 0.42 | 0.43 | |
| Debt to assets | 0.41 | 0.39 | 0.29 | 0.22 | 0.24 | |
| Net debt to EBITDA | 2.8 | 2.04 | 0.54 | 0.11 | 0.6 | |
| Current ratio | 1.01 | 1.14 | 1.55 | 1.63 | 1.59 | |
| Interest coverage | 6.41 | 6.85 | 21.32 | 37.69 | 10.97 | |
| Income quality | 3.32 | 3.11 | 1.27 | 1.17 | 1.91 | |
| Dividend Yield | 0.17 | 0.07 | 0.04 | 0.14 | 0.22 | |
| Payout ratio | 1.77 | 0.58 | 0.17 | 0.39 | 1.6 | |
| Sales general and administrative to revenue | 0.06 | 0.07 | 0.06 | 0.06 | 0.06 | |
| Research and developement to revenue | 0 | 0.01 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.07 | 0.06 | 0.07 | 0.07 | 0.07 | |
| Capex to operating cash flow | -0.75 | -0.47 | -0.28 | -0.29 | -0.42 | |
| Capex to revenue | -0.16 | -0.12 | -0.07 | -0.07 | -0.09 | |
| Capex to depreciation | -2.32 | -1.16 | -0.89 | -1.24 | -1.24 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 62.63 | 72.61 | 164.1 | 243.85 | 145.33 | |
| ROIC | 0.07 | 0.08 | 0.23 | 0.31 | 0.14 | |
| Return on tangible assets | 0.05 | 0.06 | 0.19 | 0.25 | 0.11 | |
| Graham Net | -48.43 | -45.65 | -31.88 | -19.24 | -26.13 | |
| Working capital | 5.34M | 58.88M | 283.81M | 465.83M | 294.96M | |
| Tangible asset value | 589.57M | 659.67M | 970.31M | 1.35B | 1.2B | |
| Net current asset value | -845.31M | -797.31M | -431.09M | -147.23M | -346.31M | |
| Invested capital | 1.11 | 1.03 | 0.6 | 0.42 | 0.43 | |
| Average receivables | 176.37M | 191.98M | 228.34M | 349.15M | 387.92M | |
| Average payables | 168.82M | 184M | 201.07M | 223.92M | 213.73M | |
| Average inventory | 111.05M | 105.61M | 126.43M | 191.12M | 194.87M | |
| Days sales outstanding | 45.93 | 48.53 | 43.15 | 50.85 | 51.66 | |
| Days payables outstanding | 57.59 | 61.41 | 51.59 | 43.23 | 38.7 | |
| Days of inventory on hand | 38.31 | 30.02 | 38.93 | 40.72 | 33.83 | |
| Receivables turnover | 7.95 | 7.52 | 8.46 | 7.18 | 7.07 | |
| Payables turnover | 6.34 | 5.94 | 7.08 | 8.44 | 9.43 | |
| Inventory turnover | 9.53 | 12.16 | 9.38 | 8.96 | 10.79 | |
| ROE | 0.13 | 0.15 | 0.37 | 0.44 | 0.19 | |
| Capex per share | -11.75 | -8.57 | -7.54 | -11.55 | -10.9 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 46.78 | 39.29 | 28.24 | 25.8 | 26.96 | |
| Net income per share | 14.47 | 7.08 | 0.76 | 1.5 | 4.15 | |
| Operating cash flow per share | 18.56 | 12.32 | 2.95 | 3.23 | 7.29 | |
| Free cash flow per share | 16.16 | 9.27 | -0.6 | 0.91 | 5.31 | |
| Cash per share | 26.57 | 31.64 | 12.35 | 10.93 | 14.49 | |
| Book value per share | 77.72 | 84.8 | 63.91 | 65.43 | 69.58 | |
| Tangible book value per share | 68.13 | 73.83 | 55.61 | 56.68 | 60.44 | |
| Share holders equity per share | 77.72 | 84.8 | 63.91 | 65.43 | 69.58 | |
| Interest debt per share | 32.67 | 33.38 | 33.63 | 32.09 | 30.53 | |
| Market cap | 1.9B | 2.79B | 2.04B | 1.84B | 1.93B | |
| Enterprise value | 2.01B | 2.81B | 2.46B | 2.25B | 2.24B | |
| P/E ratio | 1.65 | 4.96 | 33.81 | 15.44 | 5.87 | |
| Price to sales ratio | 2.04 | 3.57 | 3.65 | 3.59 | 3.61 | |
| POCF ratio | 5.15 | 11.39 | 34.96 | 28.67 | 13.36 | |
| PFCF ratio | 5.91 | 15.14 | -172.55 | 102.08 | 18.33 | |
| P/B Ratio | 1.23 | 1.66 | 1.61 | 1.42 | 1.4 | |
| PTB ratio | 1.23 | 1.66 | 1.61 | 1.42 | 1.4 | |
| EV to sales | 2.17 | 3.61 | 4.39 | 4.4 | 4.19 | |
| Enterprise value over EBITDA | 5 | 12.16 | 31.34 | 28.31 | 17.06 | |
| EV to operating cash flow | 5.47 | 11.5 | 42.06 | 35.08 | 15.5 | |
| EV to free cash flow | 6.28 | 15.28 | -207.56 | 124.92 | 21.27 | |
| Earnings yield | 0.15 | 0.05 | 0.01 | 0.02 | 0.04 | |
| Free cash flow yield | 0.17 | 0.07 | -0.01 | 0.01 | 0.05 | |
| Debt to equity | 0.42 | 0.39 | 0.52 | 0.48 | 0.43 | |
| Debt to assets | 0.22 | 0.21 | 0.27 | 0.26 | 0.24 | |
| Net debt to EBITDA | 0.29 | 0.11 | 5.29 | 5.17 | 2.35 | |
| Current ratio | 1.63 | 1.71 | 1.33 | 1.32 | 1.59 | |
| Interest coverage | 63.48 | 22.98 | 2.87 | 5.06 | 12.66 | |
| Income quality | 1.28 | 1.74 | 3.87 | 2.15 | 1.76 | |
| Dividend Yield | 0 | 0 | 0.21 | 0 | 0 | |
| Payout ratio | 0 | 0 | 28.32 | 0 | 0 | |
| Sales general and administrative to revenue | -0.1 | 0.06 | 0.13 | 0.14 | -0.18 | |
| Research and developement to revenue | 0.01 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | |
| Capex to operating cash flow | -0.13 | -0.25 | -1.2 | -0.72 | -0.27 | |
| Capex to revenue | -0.05 | -0.08 | -0.13 | -0.09 | -0.07 | |
| Capex to depreciation | -0.98 | -1.24 | -1.31 | -1.28 | -1.07 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 159.07 | 116.22 | 33.09 | 47.01 | 80.6 | |
| ROIC | 0.13 | 0.06 | 0.01 | 0.02 | 0.04 | |
| Return on tangible assets | 0.11 | 0.05 | 0.01 | 0.01 | 0.04 | |
| Graham Net | -19.24 | -18.35 | -31.45 | -32.13 | -26.13 | |
| Working capital | 465.83M | 554.87M | 190.77M | 182.84M | 294.96M | |
| Tangible asset value | 1.35B | 1.47B | 1.1B | 1.13B | 1.2B | |
| Net current asset value | -147.23M | -34.37M | -416.82M | -411.19M | -346.31M | |
| Invested capital | 0.42 | 0.39 | 0.52 | 0.48 | 0.43 | |
| Average receivables | 412.29M | 404.5M | 331.53M | 293.65M | 316.68M | |
| Average payables | 215.02M | 228M | 212.86M | 202.17M | 194.84M | |
| Average inventory | 207.62M | 213.34M | 197.02M | 179.05M | 167.72M | |
| Days sales outstanding | 42.43 | 42.83 | 46.86 | 51.89 | 56.83 | |
| Days payables outstanding | 41.31 | 38.04 | 41.06 | 43.62 | 40.67 | |
| Days of inventory on hand | 38.92 | 35.33 | 37.86 | 36.99 | 35.56 | |
| Receivables turnover | 2.12 | 2.1 | 1.92 | 1.73 | 1.58 | |
| Payables turnover | 2.18 | 2.37 | 2.19 | 2.06 | 2.21 | |
| Inventory turnover | 2.31 | 2.55 | 2.38 | 2.43 | 2.53 | |
| ROE | 0.19 | 0.08 | 0.01 | 0.02 | 0.06 | |
| Capex per share | -2.39 | -3.05 | -3.54 | -2.33 | -1.98 |
PCR.WA Frequently Asked Questions
What is PCC Rokita SA stock symbol ?
PCC Rokita SA is a PL stock and trading under the symbol PCR.WA
What is PCC Rokita SA stock quote today ?
PCC Rokita SA stock price is $100.6 today.
Is PCC Rokita SA stock public?
Yes, PCC Rokita SA is a publicly traded company.
Company Profile
- Volume Average 3.44K
- Market Capitalization 2.02B
- Employee 1.45K
- CEO Mr. Wieslaw Klimkowski
- Headquarters Brzeg Dolny,PL
- IPO Date 2014-06-25
-
Website
https://www.pcc.rokita.pl 
PCC Rokita SA manufactures and distributes chemical products in Poland and internationally. The company offers chloralkali, raw materials, and intermediates; polyurethanes; specialty products; and surfactants products, as well as polyols, naphthalene, and phosphorus derivatives. It serves adhesives, agrochemicals, building and construction, case, chemical reagents, detergents, fire prevention, food and fuel industry, furniture, I&I cleaning, lubricants and metalworking fluids, base oils, metallurgical, mining and drilling, oilfield, packaging, paints and coatings, personal care, pharmaceuticals, plastics, power, printing ink, pulp and paper, raw materials and intermediates, refrigeration and household appliances, sports and recreation, tanning and textile, transportation, vehicle cleaning and care, and water and wastewater treatment industries. The company is based in Brzeg Dolny, Poland. PCC Rokita SA is a subsidiary of PCC SE.
